Proliferating endothelial cell-specific expression of IGF-I receptor ribozyme inhibits retinal neovascularization (Q33232494)

24 July 2017

Proliferating endothelial cell-specific expression of IGF-I receptor ribozyme inhibits retinal neovascularization (English)

1 reference

24 July 2017

0 references

0 references

1 reference

Shaw LC

1

1 reference

24 July 2017

Pan H

2

1 reference

24 July 2017

Afzal A

3

1 reference

24 July 2017

Calzi SL

4

1 reference

24 July 2017

Spoerri PE

5

1 reference

24 July 2017

Sullivan SM

6

1 reference

24 July 2017

Grant MB

7

1 reference

24 July 2017

1 May 2006

1 reference

24 July 2017

1 reference

24 July 2017

13

1 reference

24 July 2017

752-760

1 reference

24 July 2017

9

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.gt.3302718

24 July 2017

0 references

cites work

Role for alpha 6 integrin during lens development: Evidence for signaling through IGF-1R and ERK.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302718

Insulin-like growth factor-1 contributes to neovascularization in age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302718

IGF-1 produced by cone photoreceptors regulates rod progenitor proliferation in the teleost retina

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302718

IGF-I is critical for normal vascularization of the human retina

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302718

Elevation of serum IGF-1 precedes proliferative diabetic retinopathy in Mauriac's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302718

Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease. Studies in nondiabetic and diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302718

Decreased expression of the insulin-like growth factor 1 receptor by ribozyme cleavage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302718

Postnatal serum insulin-like growth factor I deficiency is associated with retinopathy of prematurity and other complications of premature birth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302718

Optimization of cationic lipid/DNA complexes for systemic gene transfer to tumor lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302718

Cationic lipid-based delivery system for systemic cancer gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302718

Angiogenesis inhibitors in the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302718

Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302718

PEDF: a pigment epithelium-derived factor with potent neuronal differentiative activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302718

Periocular injection of an adenoviral vector encoding pigment epithelium-derived factor inhibits choroidal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302718

Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302718

Blocking the insulin-like growth factor-I receptor as a strategy for targeting cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302718

Insulin-like growth factor receptor-1 as an anti-cancer target: blocking transformation and inducing apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302718

The contradictions of the insulin-like growth factor 1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302718

The IGF-I receptor in cancer research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302718

In vivo effects of the human type I insulin-like growth factor receptor antibody A12 on androgen-dependent and androgen-independent xenograft human prostate tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302718

Combination therapy enhances the inhibition of tumor growth with the fully human anti-type 1 insulin-like growth factor receptor monoclonal antibody CP-751,871.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302718

Inhibition of insulin-like growth factor I receptor autophosphorylation by novel 6-5 ring-fused compounds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302718

Potential therapeutic strategies to interrupt insulin-like growth factor signaling in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302718

The cyclolignan PPP induces activation loop-specific inhibition of tyrosine phosphorylation of the insulin-like growth factor-1 receptor. Link to the phosphatidyl inositol-3 kinase/Akt apoptotic pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302718

Combined effects of tamoxifen and a chimeric humanized single chain antibody against the type I IGF receptor on breast tumor growth in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302718

Insulin-like growth factors and neoplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302718

The therapeutic potential of agents targeting the type I insulin-like growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302718

Improving the transfection efficiency of post-mitotic neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302718

Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302718

Basic FGF-induced down-regulation of IGF-I mRNA in cultured rat Müller cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302718

7 January 2021

Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302718

7 January 2021

Insulin-like growth factors. Studies in diabetics with and without retinopathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302718

7 January 2021

Insulin-like growth factors in vitreous. Studies in control and diabetic subjects with neovascularization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302718

7 January 2021

Association of Elevated IGF-I Levels With Increased Retinopathy in Late-Onset Diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302718

7 January 2021

A two-year follow-up study of serum insulinlike growth factor-I in diabetics with retinopathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302718

7 January 2021

Insulin-like growth factor I as an angiogenic agent. In vivo and in vitro studies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302718

7 January 2021

Targeting angiogenesis with vascular endothelial growth factor receptor small-molecule inhibitors: novel agents with potential in lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302718

7 January 2021

Free insulin growth factor-I and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302718

7 January 2021

Increased levels of platelet-derived growth factor in vitreous fluid of patients with proliferative diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302718

7 January 2021

Essential role of growth hormone in ischemia-induced retinal neovascularization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302718

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3302718

1 reference

Dimensions Publication ID

24 July 2017

0 references

1 reference